X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41747) 41747
Magazine Article (87) 87
Book Chapter (24) 24
Book / eBook (13) 13
Conference Proceeding (5) 5
Reference (3) 3
Publication (2) 2
Dissertation (1) 1
Newsletter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40860) 40860
combined modality therapy (33026) 33026
female (26167) 26167
male (23671) 23671
middle aged (20475) 20475
adult (17386) 17386
aged (15965) 15965
oncology (13534) 13534
treatment outcome (13247) 13247
antineoplastic combined chemotherapy protocols - therapeutic use (9596) 9596
chemotherapy (8279) 8279
cancer (7681) 7681
antineoplastic combined chemotherapy protocols - adverse effects (6389) 6389
surgery (6257) 6257
follow-up studies (6064) 6064
care and treatment (6004) 6004
radiotherapy (5965) 5965
retrospective studies (5494) 5494
adolescent (5395) 5395
aged, 80 and over (5031) 5031
neoplasm staging (4902) 4902
prognosis (4848) 4848
therapy (4359) 4359
survival rate (4034) 4034
child (3960) 3960
medicine & public health (3650) 3650
hematology (3482) 3482
risk factors (3453) 3453
prospective studies (3182) 3182
survival analysis (3113) 3113
disease-free survival (3101) 3101
survival (3027) 3027
time factors (3002) 3002
health aspects (2875) 2875
research (2803) 2803
young adult (2783) 2783
antineoplastic agents - therapeutic use (2777) 2777
cisplatin - administration & dosage (2713) 2713
analysis (2649) 2649
radiation-therapy (2493) 2493
child, preschool (2439) 2439
radiology, nuclear medicine & medical imaging (2382) 2382
radiotherapy - adverse effects (2380) 2380
combined modality therapy - methods (2377) 2377
radiotherapy dosage (2355) 2355
recurrence (2319) 2319
management (2268) 2268
animals (2256) 2256
antineoplastic combined chemotherapy protocols - administration & dosage (2225) 2225
carcinoma (2209) 2209
hematology, oncology and palliative medicine (2197) 2197
combined modality therapy - adverse effects (2182) 2182
trial (2119) 2119
antineoplastic agents - adverse effects (2114) 2114
drug administration schedule (2102) 2102
cisplatin (2093) 2093
clinical trials (2059) 2059
patients (2009) 2009
radiation (1973) 1973
fluorouracil - administration & dosage (1938) 1938
chemotherapy, adjuvant (1937) 1937
drug therapy (1901) 1901
tumors (1838) 1838
quality of life (1810) 1810
abridged index medicus (1770) 1770
remission induction (1758) 1758
radiation therapy (1674) 1674
clinical trials as topic (1663) 1663
transplantation (1659) 1659
dose-response relationship, drug (1644) 1644
medicine, general & internal (1636) 1636
children (1614) 1614
randomized controlled trials as topic (1588) 1588
risk assessment (1585) 1585
clinical neurology (1574) 1574
infant (1550) 1550
metastasis (1537) 1537
risk (1530) 1530
toxicity (1525) 1525
cyclophosphamide - administration & dosage (1517) 1517
pediatrics (1516) 1516
patient outcomes (1472) 1472
psychiatry (1455) 1455
diagnosis (1435) 1435
cisplatin - adverse effects (1390) 1390
pharmacology & pharmacy (1377) 1377
doxorubicin - administration & dosage (1365) 1365
severity of illness index (1361) 1361
breast cancer (1350) 1350
antineoplastic agents - administration & dosage (1341) 1341
randomized-trial (1339) 1339
breast neoplasms - drug therapy (1326) 1326
lung neoplasms - drug therapy (1299) 1299
kaplan-meier estimate (1298) 1298
drug therapy, combination (1296) 1296
efficacy (1280) 1280
immunotherapy (1279) 1279
mortality (1273) 1273
usage (1271) 1271
cardiac & cardiovascular systems (1256) 1256
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37651) 37651
German (1675) 1675
French (757) 757
Japanese (555) 555
Russian (499) 499
Spanish (478) 478
Chinese (228) 228
Italian (142) 142
Polish (52) 52
Dutch (44) 44
Hungarian (26) 26
Portuguese (20) 20
Bulgarian (18) 18
Czech (16) 16
Finnish (16) 16
Ukrainian (11) 11
Norwegian (10) 10
Romanian (10) 10
Danish (7) 7
Hebrew (7) 7
Swedish (5) 5
Icelandic (4) 4
Korean (4) 4
Turkish (4) 4
Croatian (3) 3
Lithuanian (3) 3
Serbian (3) 3
Bosnian (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 61, Issue 4, pp. 705 - 711
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
.... Active therapies are often associated with increased risk of haematological or neurological toxicity... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 24, pp. 2516 - 2527
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than conventional-dose therapy... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 286 - 295
.... Methods and Materials ASCENDE-RT (Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | CONFORMAL RADIATION-THERAPY | ONCOLOGY | CLINICALLY LOCALIZED ADENOCARCINOMA | INTENSITY-MODULATED RADIOTHERAPY | TOXICITY | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | Fecal Incontinence - epidemiology | Follow-Up Studies | Humans | Middle Aged | Urogenital System - radiation effects | Diarrhea - epidemiology | Male | Erectile Dysfunction - epidemiology | Pelvis | Gastrointestinal Hemorrhage - epidemiology | Feasibility Studies | Incidence | Time Factors | Aged, 80 and over | Gonadotropin-Releasing Hormone - therapeutic use | Fecal Incontinence - etiology | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Re-Irradiation - adverse effects | Brachytherapy - methods | Gonadotropin-Releasing Hormone - adverse effects | Logistic Models | Rectum - radiation effects | Combined Modality Therapy - adverse effects | Erectile Dysfunction - etiology | Urinary Incontinence - etiology | Re-Irradiation - methods | Disease-Free Survival | Gastrointestinal Hemorrhage - etiology | Urination Disorders - epidemiology | Urination Disorders - etiology | Intention to Treat Analysis | Androgen Antagonists - therapeutic use | Diarrhea - etiology | Radiotherapy, Conformal - adverse effects | Urinary Incontinence - epidemiology | Aged | Combined Modality Therapy - methods | Androgen Antagonists - adverse effects | Brachytherapy - adverse effects | Radioisotope brachytherapy | Impotence | Clinical trials | Health aspects | Prostate cancer | Risk factors | Morbidity | Prevalence studies (Epidemiology) | Index Medicus | PROSTATE | DISEASE INCIDENCE | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION HAZARDS | MEN | RADIOLOGY AND NUCLEAR MEDICINE | BRACHYTHERAPY | GY RANGE 10-100
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 820 - 829
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 1945-7197, 2016, Volume 101, Issue 11, pp. 3922 - 3937
...Summary of Recommendations 1. Insulin pump therapy without sensor augmentation 1.1 We recommend continuous subcutaneous insulin infusion (CSII) over analog... 
MULTIPLE DAILY INJECTIONS | COMPLICATIONS TRIAL/EPIDEMIOLOGY | SEVERE HYPOGLYCEMIA | BOLUS CALCULATOR | AMERICAN ASSOCIATION | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | IMPROVED GLYCEMIC CONTROL | PUMP THERAPY | METABOLIC-CONTROL | EUROPEAN ASSOCIATION | Endocrinology - methods | Drug Monitoring - trends | Combined Modality Therapy - trends | Humans | Diabetes Mellitus, Type 2 - diet therapy | Diabetes Mellitus, Type 1 - therapy | Hypoglycemia - prevention & control | Exercise | Monitoring, Ambulatory - trends | Hypoglycemic Agents - administration & dosage | Monitoring, Ambulatory - adverse effects | Diabetes Mellitus, Type 2 - therapy | Adult | Hypoglycemia - chemically induced | Patient Education as Topic | Precision Medicine | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Combined Modality Therapy - adverse effects | Evidence-Based Medicine | Consensus | Insulin Infusion Systems - trends | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | International Agencies | Diabetes Mellitus, Type 1 - blood | Societies, Scientific | Diabetes Mellitus, Type 1 - diet therapy | Diet, Diabetic - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use
Journal Article